BridgeBio Pharma Inc (BBIO) Reports Q3 2023 Financial Results

Revenue of $4.1 Million and Cash Position of $522 Million

Related Keywords

,Bridgebio Pharma Inc ,European Medicines Agency ,Bio Pharma Inc ,Drug Administration ,Key Program Updates ,New Drug Application ,Cash Equivalents ,Equity Financing ,Egulatory Meetings ,